Benefit to cost of vaccination against mycoplasma hyopneumoniae in pig herds under Belgian market conditions from 1996 to 2000

Livestock Production Science

Volumn 83, Issue 1, 2003, Pages 85-93

  Maes, Dominiek ^a   Verbeke, Wim ^a   Vicca, Jo ^a   Verdonck, Marc ^a   De Kruif, Aart ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Economic analysis; Mycoplasma hyopneumoniae; Pig; Respiratory disease; Vaccination

Indexed keywords

MYCOPLASMA; MYCOPLASMA HYOPNEUMONIAE; SUS SCROFA;

EID: 0141795558     PISSN: 03016226     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-6226(03)00039-3     Document Type: Article

References (24)

1. Bilic, V., Lipej, Z., Valpotic, I., Habrun, B., Humski, A., Njari, B., 1996. Mycoplasmal pneumonia in pigs in Croatia: first evaluation of a vaccine in fattening pigs. Acta Vet. Hung. 44, 287-293.
2. Charlier, P., Jambers, B., Martinod, S., 1993. Efficacité d'un vaccin contre Mycoplasma hyopneumoniae utilisé dans des élevages infectés en France. J. Rech. Porc. France 25, 345-350.
3. Clark, K., 1999. Mycoplasma hyopneumoniae: serology/vaccinology. In: Proceedings 30th Annual Meeting AASP St. Louis Missouri, USA, pp. 365-369.
4. CLE, 2001. Technical and economic results of pig farming on farms of the CLE accountancy network. CLE, Center for Agricultural Economics, Ministry of Agriculture, Brussels.
5. Dee, S., 1994. Apparent prevention of Mycoplasma hyopneumoniae infection in growing pigs with a low-cost modified medicated-early-weaning program. J. Swine Health Prod. 6, 7-12.
6. Dohoo, I., Montgomery, M., 1996. A field trial to evaluate a Mycoplasma hyopneumoniae vaccine: effects on lung lesions and growth rates in swine. Can. Vet. J. 37, 299-302.
7. Huirne, R., Dijkhuizen, A., 1997. Basic methods of economic analysis. In: Dijkhuizen, A.A., Morris, R.S. (Eds.), Animal Health Economics: Principles and Applications. University of Sydney, The Postgraduate Foundation Publisher, pp. 25-40.
8. Kyriakis, S., Elexopoulos, C., Vlemmas, J., Sarris, K., Lekkas, S., Koutsoviti-Papadopoulou, M., Saoulidis, K., 2001. Field study on the efficacy of two different vaccination schedules with Hyoresp® in a Mycoplasma hyopneumoniae-infected commercial pig unit. J. Vet. Med. B 48, 675-684.
9. LeGrand, A., Kobisch, M., 1996. Comparaison de l'utilisation d'un vaccin et d'un traitement antibiotique séquentiel dans un élevage infecté par Mycoplasma hyopneumoniae. Vet. Res. 27, 241-253.
10. Maes, D., 1998. Respiratory disease in slaughter pigs: epidemiological aspects and effect of vaccination against Mycoplasma hyopneumoniae. PhD thesis, Faculty of Veterinary Medicine, Ghent University, pp. 227.
11. Maes, D., Deluyker, H., Verdonck, M., Castryck, F., Miry, C., Vrijens, B., de Kruif, A., 1998. Effect of vaccination against Mycoplasma hyopneumoniae in herds with a continuous production system. J. Vet. Med. B 45, 495-505.
12. Maes, D., Deluyker, H., Verdonck, M., Castryck, F., Miry, C., Vrijens, B., Verbeke, W., Viaene, J., de Kruif, A., 1999. Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with an all-in/all-out production system. Vaccine 17, 1024-1034.
13. Maes, D., Deluyker, H., Verdonck, M., Castryck, F., Miry, C., Vrijens, B., de Kruif, A., 2000. Herd factors associated with the seroprevalences of four major respiratory pathogens in slaughter pigs from farrow-to-finish pig herds. Vet. Res. 31, 313-327.
14. Mateusen, B., Maes, D., Hoflack, G., Verdonck, M., de Kruif, A., 2000. A comparative study between the preventive use of tilmicosin phosohate (Pulmotil premix®) and Mycoplasma hyopneumoniae vaccination in a pig herd with chronic respiratory disease. J. Vet. Med. B 48, 733-741.
15. Mateusen, B., Maes, D., Van Goubergen, M., Verdonck, M., de Kruif, A., 2002. Effectiveness of strategic medication with lincomycin hydrochloride and/ or vaccination against Mycoplasma hyopneumoniae for controlling chronic respiratory disease in a herd of pigs. Vet. Rec. 151, 135-140.
16. Martin, S., Meek, A., Willeberg, P., 1994. Descriptive epidemiology. In: Veterinary Epidemiology. Principles and Methods. Iowa State University Press, Ames Iowa, USA, pp. 79-120.
17. Pallarés, F., Gómez, S., Muñoz, A., 2001. Evaluation of the zootechnical parameters of vaccinating against swine enzootic pneumonia under field conditions. Vet. Rec. 148, 104-107.
18. Pallarés, F., Gómez, S., Ramis, G., Seva, J., Muñoz, A., 2000. Vaccination against swine enzootic pneumonia in field conditions: effect on clinical, pathological, zootechnical and economic parameters. Vet. Res. 31, 573-582.
19. Pointon, A., Heap, P., McLoud, P., 1985. Enzootic pneumonia of pigs in South Australia - factors relating to incidence of disease. Aust. Vet. J. 62, 98-100.
20. Rautiainen, E., Virtala, A.-M., Wallgren, P., Saloniemi, H., 2000. Varying effects of infections with Mycoplasma hyopneumoniae on the weight gain recorded in three different multisource fattening pig herds. J. Vet. Med. B 47, 461-469.
21. Ross, R., 1999. Mycoplasmal diseases. In: Straw, B.E., D'Allaire, S., Mengeling, W.L., Taylor, D.J. (Eds.), Diseases of Swine, 8th ed. Iowa State University Press, Ames, IA, pp. 495-509.
22. Schatzmann, E., Keller, H., Grest, P., Lorenz, D., Burri, W., 1996. Feldversuche mit einer Vakzine gegen die Enzootische Pneumonie (EP) der Schweine. Schweiz. Arch. Tierheilkd. 138, 483-489.
23. Verbeke, W., 2001. The emerging role of traceability and information in demand-oriented livestock production. Outlook Agr. 30, 249-255.
24. Vraa-Andersen, L., Christensen, G., 1993. Mycoplasma induced pneumonia in pigs (enzootic pneumonia). A clinical trial of the vaccine Suvaxyn M. hyo®. Dansk Vet. Tidskr. 76, 129-132.